Nebula Research & Development LLC Morphic Holding, Inc. Transaction History

Nebula Research & Development LLC

  • $836 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$26.64 - $40.31 $408,870 - $618,677
15,348 Added 95.05%
31,495 $1.11 Billion
Q4 2023

Feb 14, 2024
BUY
$19.95 - $31.0 $322,132 - $500,557
16,147 New
16,147 $466 Million
Q2 2023

Aug 14, 2023
BUY
$34.33 - $62.11 $339,146 - $613,584
9,879 New
9,879 $566 Million

Others Institutions Holding MORF

# of Institutions
9
Shares Held
4.71M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email